Ornithine phenylacetate revisited. - Wikidata - awgldk - TriplyDB

Ornithine phenylacetate revisited.

Ornithine phenylacetate revisited.

http://www.wikidata.org/entity/Q38086119

about

Glycine and hyperammonemia: potential target for the treatment of hepatic encephalopathy.The Pharmabiotic Approach to Treat Hyperammonemia.

P2860

Q39658369-743D6FD8-EC49-4173-AA65-A1E7E6A2CD9C Q47831420-65F91814-37E0-4EC1-AEC3-FC193CC65F0C

P2860

Ornithine phenylacetate revisited.

http://www.wikidata.org/entity/Q38086119

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Ornithine phenylacetate revisited.

@en

type

label

Ornithine phenylacetate revisited.

@en

prefLabel

Ornithine phenylacetate revisited.

@en

P1433

Q38086119-D5EE5BDE-F7AD-4F5E-95EE-9443299268C1

P1476

Q38086119-98D9989B-F7A4-4063-881C-F89F250E0A10

P2093

Q38086119-1C2A5BC5-A289-4C1C-97F2-127521C90F02

Q38086119-234ED8A6-31A2-4734-828B-98854A36CEAD

Q38086119-9B36EB3B-E6B8-411D-97C1-E9F8917EFC2E

Q38086119-F733978D-123E-4960-B6F6-0208E5B24E83

P2860

Q38086119-04A97216-8C67-4A72-B392-38063E897502

Q38086119-0812D373-DF6D-47CF-AD62-71A8CEC568B4

Q38086119-0A82A98F-460D-46BA-BBB9-E78AC7ED418D

Q38086119-0F40DE2C-FF9C-4D39-803C-ABDA4FD1509D

Q38086119-15BA7114-C824-46EE-812C-6FFD8A185071

Q38086119-16EC1536-A204-49E1-B22B-12BBD4ED8364

Q38086119-1FD7E5A3-EAD9-4357-856C-2C144FF3A7DB

Q38086119-2DB3A743-9144-49DF-B666-902FE4476A29

Q38086119-387B1857-5392-4999-819A-DE7393A42133

Q38086119-46AB2C8F-A8BC-4383-8EA1-E77B6E94F838

P2888

Q38086119-DEEC4D73-4C83-4E79-BD9A-A6B3ED09B36B

P304

Q38086119-857B6BEF-E4EA-4495-B2FB-0DBA71F398BA

P31

Q38086119-3D9DE484-4AF7-49AF-89DF-D9C06AA759F9

P356

Q38086119-9EDBA586-A120-4056-AD31-EB8C5B80986E

P433

Q38086119-7553116D-A224-4A72-875A-7F094B740778

P478

Q38086119-60D6AF97-2CAD-4749-93DA-7C7AC2734B7F

P577

Q38086119-A4C8C33C-3B31-494D-8931-AD7D1B64B92D

P6179

Q38086119-D6C305AC-4DFC-4F78-9325-75C4DF661B0B

P698

Q38086119-1D61EE1F-B27E-46DB-9746-0383A247CCD2

P356

S11011-013-9391-5

P1433

Metabolic Brain Disease

P1476

Ornithine phenylacetate revisited.

@en

P2093

Lorette Noiret

http://www.w3.org/2001/XMLSchema#string

Maria Jover-Cobos

http://www.w3.org/2001/XMLSchema#string

Rajiv Jalan

http://www.w3.org/2001/XMLSchema#string

Yalda Sharifi

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of methylarginine metabolism impairs vascular homeostasis

NF-kappaB regulation in the immune system

Rifaximin treatment in hepatic encephalopathy

Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial

Motor-evoked potentials in awake rats are a valid method of assessing hepatic encephalopathy and of studying its pathogenesis.

Interorgan ammonia metabolism in liver failure.

Identifying the direct effects of ammonia on the brain.

The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation.

Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications.

Pharmacotherapy of hepatic encephalopathy in cirrhosis.

P2888

s11011-013-9391-5

P304

327-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11011-013-9391-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020472715

http://www.w3.org/2001/XMLSchema#string

P698

23456516

http://www.w3.org/2001/XMLSchema#string